Milano, 14 gennaio 2019

Gli articoli apparsi nel corso della settimana sono i seguenti:

• Peters S, Dafni U, Boyer M, et al. Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III Non-Small Cell Lung Cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP). Annals of Oncology 2019 Jan 8  [Epub ahead of print]
  Vai alla pagina della rivista
   

• Thorp N, Gandola L. Management of Ependymoma in Children, Adolescents and Young Adults. Clinical Oncology 2019 Jan 4 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Ricci R, Martini M, Ravegnini G, et al. Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents. Clinical Epigenetics 2019 Jan 7; 11(1):2.
  Vai alla pagina della rivista
   

• Skapek SX, Ferrari A, Gupta AA, et al. Rhabdomyosarcoma. Nat Rev Dis Primers. 2019; 5(1):1.
  Vai alla pagina della rivista
   

• Modest DP, Rivera F, Bachet JB, et al. Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: a retrospective analysis of two randomised trials. International Journal of Cancer 2019 Jan 7 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Rizzolo P, Zelli V, Silvestri V, et al. Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy. International Journal of Cancer 2019 Jan 7 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Martin-Broto J, Stacchiotti S, Lopez-Pousa A, et al. Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial. Lancet Oncology 2019;20(1): 134-144.
  Vai alla pagina della rivista
   

Milano, 7 gennaio 2019

Gli articoli apparsi nel corso della settimana sono i seguenti:
 

• Guida L, Roux FE, Massimino M, et al. Safety and efficacy of Endoscopic Third Ventriculostomy in Diffuse Intrinsic Pontine Glioma related hydrocephalus: a Systematic Review. World Neurosurgery 2018 Dec 29  [Epub ahead of print]
  Vai alla pagina della rivista
   

• Vukovic V, Lillini R, Lupi S, et al. Identifying people at risk for influenza with low vaccine uptake based on deprivation status: a systematic review. European Journal of Public Health 2018 Dec 28 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Albert CM, Davis JL, Federman N, et al. TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening. Journal of Clinical Oncology 2018 Dec 28 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Cetti E, Di Marco T, Mauro G, et al. Mitosis perturbation by MASTL depletion impairs the viability of thyroid tumor cells. Cancer Letters 2019; 442: 362-372.
  Vai alla pagina della rivista
   

• Mavaddat N, Michailidou K, Dennis J, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American Journal of Human Genetics 2019; 104(1): 21-34.
  Vai alla pagina della rivista
   

• Vernieri C, Galli F, Ferrari L, et al. Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis. Oncologist 2019 Jan 3 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Pastorino U, Morelli D, Leuzzi G, Rolli L, et al. Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy. Annals of Surgical Oncology 2019 Jan 3. doi: 10.1245/s10434-018-07116-7. [Epub ahead of print]
  Vai alla pagina della rivista
   

Milano, 31 dicembre 2018

Gli articoli apparsi nel corso della settimana sono i seguenti:
 

• Triulzi T, Forte L, Regondi V, et al. HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy. Oncoimmunology 2018; 8(1): e1512942.
  Vai alla pagina della rivista
   

• Frezza AM, Botta L, Trama A, et al. Chordoma: update on disease, epidemiology, biology and medical therapies. Current Opinion in Oncology 2018 Dec 24 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Ward HA, Murphy N, Weiderpass E, et al. Gallstones and incident colorectal cancer in a large pan-European cohort study. International Journal of Cancer 2018 Dec 26 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Baumeister SE, Schlesinger S, Aleksandrova K, et al. Association of Physical Activity and Risk of Hepatobiliary Cancers: A Multinational Cohort Study. Journal of Hepatology 2018 Dec 21 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Larkin J, Brown MP, Arance AM, et al. An open-label, multicentre safety study of vemurafenib in patients with BRAF(V600)-mutant metastatic melanoma: final analysis and a validated prognostic scoring system. European Journal of Cancer 2018;107: 175-185.
  Vai alla pagina della rivista
   

• Schwartz S, Szeto C, Tian Y, et al. Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using protomi analysis of O6-methylguanine-DNA-methyltransferase. European Journal of Cancer 2018; 107: 164-174.
  Vai alla pagina della rivista
   

• Hu MI, Elisei R, Dedecjus M, et al. Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer. Endocrine-Related Cancer 2019; 26(2): 241-250.
  Vai alla pagina della rivista
   

• Corti F, Nichetti F, Raimondi A, et al. Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives. Cancer Treatment Reviews 2019; 72: 45-55.
  Vai alla pagina della rivista
   

• Bonomi S, Sala L, Gennaro M, et al. Skin-Reducing Mastectomy and Direct-to-Implant Breast Reconstruction With Submuscular-Dermal-Mesh Pocket. Annals of Plastic Surgery 2019; 82(1): 19-27.
  Vai alla pagina della rivista
   

• Necchi A, Giannatempo P, Raggi D, et al. An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis. European Urology 2019; 75(1): 201-203.
  Vai alla pagina della rivista
   

Milano, 24 dicembre 2018

Gli articoli apparsi nel corso della settimana sono i seguenti:
 

• Triulzi T, Forte L, Regondi V, et al. HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy. Oncoimmunology. 2018; 8(1): e1512942.
  Vai alla pagina della rivista
   

• Nicola M, Onorati M, Bertola G, et al. Primary thyroid biphasic synovial sarcoma and synchronous papillary carcinoma: report of a remarkable case. Pathologica. 2018; 110(2): 106-110. 
   

• Guadagni S, Aigner K, Zoras O, et al. Isolated thoracic perfusion in lung metastases from breast cancer: a retrospective observational study. Updates in Surgery 2018 Dec 12 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Ierardi AM, Petrillo M, Coppola A, et al. Percutaneous microwave ablation of renal angiomyolipomas in tuberous sclerosis complex to improve the quality of life: preliminary experience in an Italian center. La Radiologia Medica 2018 Dec 11 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Indini A, Di Guardo L, Cimminiello C, et al. Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma. Journal of Cancer Research and Clinical Oncology 2018 Dec 11 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Zamora-Ros R, Alghamdi MA, Cayssials V, et al. Coffee and tea drinking in relation to the risk of differentiated thyroid carcinoma: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. European Journal of Nutrition 2018 Dec 10 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Mussetti A, Martinetti N, Cieri N, Pennisi M, Dodero A, Corradini P. Real-life feasibility of salvage allogeneic transplantation in peripheral T-cell lymphomas. Bone Marrow Transplantation 2018 Dec 7 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Seijo LM, Peled N, Ajona D, et al. Biomarkers in lung cancer screening: achievements, promises and challenges.Journal of Thoracic Oncology 2018 Dec 4  [Epub ahead of print]
  Vai alla pagina della rivista
   

• Gasull M, Pumarega J, Kiviranta H, et al. Methodological issues in a prospective study on plasma concentrations of persistent organic pollutants and pancreatic cancer risk within the EPIC cohort. Environmental Research 2018 Nov 23; 169:417-433.
  Vai alla pagina della rivista
   

• Stacchiotti S, Simeone N, Lo Vullo S, et al. Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study. European Journal of Cancer 2018; 106: 225-233.
  Vai alla pagina della rivista
   

• Garassino MC, Crinò L, Catino A, et al. Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.
  Tumour Biology 2018; 40(11): 1010428318815047.
  Vai alla pagina della rivista
   

• Casiraghi E, Huber V, Frasca M, et al. A novel computational method for automatic segmentation, quantification and comparative analysis of immunohistochemically labeled tissue sections. BMC Bioinformatics. 2018; 19(Suppl 10): 357.
  Vai alla pagina della rivista

Milano, 17 dicembre 2018

• Riggio E, Toffoli E, Tartaglione C, et al. Local safety of immediate reconstruction during primary treatment of breast cancer. Direct-to-implant versus expander-based surgery. Journal of Plastic, Reconstructive & Aesthetic Surgery 2018 Nov 2 [Epub ahead of print]
  Vai alla pagina della rivista
   

Per maggiori informazioni:

“Leggi l'abstract a cura dell’Istituto Nazionale dei Tumori (PDF)"

--------------------------------------------------------------------------------------------------------------------------------------------------------

Gli altri articoli apparsi nel corso della settimana sono i seguenti:

• Vernieri C, Pusceddu S, Fucà G, et al. Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs). International Journal of Cancer 2018 Dec 5 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Cimminiello C, Indini A, Di Guardo L, et al. Pembrolizumab in the treatment of advanced/metastatic melanoma: a single-center institution experience. Melanoma Research 2018 Dec 4 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Tazzari M, Brich S, Tuccitto A, et al. Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types. Journal of Immunology Research 2018 Oct 29; 2018: 5804230.
  Vai alla pagina della rivista
   

• Grioni S, Agnoli C, Krogh V, et al. Dietary cadmium and risk of breast cancer subtypes defined by hormone receptor status: a prospective cohort study. International Journal of Cancer 2018 Dec 4 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Fucà G, Hindi N, Ray-Coquard I, et al. Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study. The Oncologist 2018 Dec 5 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Bogani G, Chiappa V, Lorusso D, et al. Tailoring adjuvant treatment in patients with uterine cancer. Lancet Oncology 2018;19(12): e655.
  Vai alla pagina della rivista
   

• Solima E, Pino I, Scagnelli G, et al. "When you hear hoofbeats,think of horses not zebras": a case of bladder endometriosis in menopause.  Journal of Minimally Invasive Gynecology 2018 Nov 29  [Epub ahead of print]
  Vai alla pagina della rivista
   

• Virdis M, Monteleone M, Sposito C, et al. Hepatocellular Carcinoma in Abernethy Malformation: A Rare Occurrence of Congenital Complete Portosystemic Shunt. Journal of Vascular and Interventional Radiology 2018; 29(12): 1775-1778.
  Vai alla pagina della rivista
   

• Occhipinti V, Farina L, Viganò M, et al. Concomitant therapy with direct-acting antivirals and chemoimmunotherapy in HCV-associated diffuse large B-cell lymphoma. Digestive and Liver Disease 2018 Nov 3 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Perez-Gracia JL, Loriot Y, Rosenberg JE, Powles T, et al. Corrigendum re: "Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens". European Urology 2018 Nov 27 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Caiola E, Falcetta F, Giordano S, et al. Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach. Journal of Experimental & Clinical Cancer Research 2018; 37(1): 302.
  Vai alla pagina della rivista
   

• Del Bene G, Calabrò F, Giannarelli D, et al. Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database. Frontiers in Oncology 2018 Nov 19; 8:463.
  Vai alla pagina della rivista
   

• Huyghe JR, Bien SA, Harrison TA, et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nature Genetics 2018 Dec 3 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Cohen EEW, Soulières D, Le Tourneau C, et al. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet 2018 Nov 30 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Li K, Anderson G, Viallon V, Arveux P, et al. Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts. Breast Cancer Research 2018; 20(1): 147.
  Vai alla pagina della rivista
   

• Franchi A, Bishop JA, Coleman H, et al. Data Set for the Reporting of Carcinomas of the Nasal Cavity and Paranasal Sinuses: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting. Archives of Pathology & Laboratory Medicine 2018 Nov 30 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Cantù P, Tarantino I, Baldan A, et al. Endo-therapies for biliary duct-to-duct anastomotic stricture after liver transplantation: outcomes of a nationwide survey. Liver International 2018 Nov 30 [Epub ahead of print]
  Vai alla pagina della rivista
   

Milano, 10 dicembre 2018

• Triulzi T, Regondi V, De Cecco L, et al. Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit. British Journal of Cancer 2018 Nov 27 [Epub ahead of print]
  Vai alla pagina della rivista
   

Per maggiori informazioni:

“Leggi l'abstract a cura dell’Istituto Nazionale dei Tumori (PDF)"

--------------------------------------------------------------------------------------------------------------------------------------------------------

Gli altri articoli apparsi nel corso della settimana sono i seguenti:

• Deraco M, Nizri E, Glehen O, et al. Well differentiated papillary peritoneal mesotelioma treated by cytoreduction and hyperthermic intraperitoneal chemotherapy-the experience of the PSOGI registry. European Journal of Surgical Oncology 2018 Oct 19 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Costas L, Lujan-Barroso L, Benavente Y, et al. Reproductive factors, exogenous hormone use and risk of B-cell non-Hodgkin lymphoma in a cohort of women from the European Prospective Investigation into Cancer and Nutrition. American Journal of Epidemiology 2018 Nov 27 [Epub ahead of print]
  Vai alla pagina della rivista
   

• D'Agostino M, De Paoli L, Conticello C, et al. Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. Critical Reviews in Oncology/Hematology 2018; 132: 9-16.
  Vai alla pagina della rivista
   

• Bogani G, Ditto A, Raspagliesi F. Early diagnosis in endometrial cancer minimizes the impact of treatments. American Journal of Obstetric and Gynecology 2018; 219(6): 631-632.
  Vai alla pagina della rivista
   

• Mehlig K, Bogl LH, Hunsberger M, et al. Children's propensity to consume sugar and fat predicts regular alcohol consumption in adolescence. Public Health Nutrition 2018; 21(17): 3202-3209.
  Vai alla pagina della rivista
   

• Bushati M, Rovers KP, Sommariva A, et al. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). European Journal of Surgical Oncology 2018; 4(12): 1942-1948.
  Vai alla pagina della rivista
   

• Cremonesi M, Ferrari ME, Bodei L, et al. Correlation of dose with toxicity and tumour response to (90)Y- and (177)Lu-PRRT provides the basis for optimization through individualized treatment planning. European Journal of Nuclear Medicine and Molecular Imaging 2018; 45(13): 2426-2441.
  Vai alla pagina della rivista
   

• Bologna M, Corino VDA, Montin E, et al.  Assessment of Stability and Discrimination Capacity of Radiomic Features on Apparent Diffusion Coefficient Images. Journal of Digital Imaging 2018; 31(6): 879-894.
  Vai alla pagina della rivista
   

• Cucchetti A, Sposito C, Pinna AD et al. Relative Survival Instead of Overall Survival Should Be Used as Outcome When Analyzing the Effect of Age After Treatment of Hepatocellular Carcinoma. Annals of Surgery 2018; 268(6): e76.
  Vai alla pagina della rivista
   

• Hjermstad MJ, Aass N, Aielli F, et al. Characteristics of the case mix, organisation and delivery in cancer palliative care: a challenge for good-quality research. BMJ Supportive & Palliative Care 2018; 8(4): 456-467.
  Vai alla pagina della rivista
   

• Ferrari A, Gasparini P, Gill J, Gorlick R. Challenges of Clinical Management of Adolescent and Young Adults With Bone and Soft Tissue Sarcoma. Cancer Journal 2018; 24(6):301-306.
  Vai alla pagina della rivista
   

• Cremolini C, Rossini D, Dell'Aquila E, et al. Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial. JAMA Oncology 2018 Nov 21 [Epub ahead of print] 
  Vai alla pagina della rivista
   

• Corti F, Nichetti F, Raimondi A, et al. Targeting the I3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives. Cancer Treatment Reviews 2018; 72: 45-55.
  Vai alla pagina della rivista
   

• Sironi G, Barr RD, Ferrari A. Models of Care-There Is More Than One Way to Deliver. Cancer Journal 2018; 24(6): 315-320.
  Vai alla pagina della rivista
   

Milano, 3 dicembre 2018

• Bossi P, Miceli R, Benasso M, et al. Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials. Head & Neck 2018 Nov 17 [Epub ahead of print]
  Vai alla pagina della rivista
   

Per maggiori informazioni:

“Leggi l'abstract a cura dell’Istituto Nazionale dei Tumori (PDF)"

--------------------------------------------------------------------------------------------------------------------------------------------------------

Gli altri articoli apparsi nel corso della settimana sono i seguenti:

• Bogani G, Leone Roberti Maggiore U, Chiappa V, et al. The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer.
  International Journal of Gynaecology and Obstetrics 2018; 143(3): 319-324.
  Vai alla pagina della rivista
   

• Fiore M, Gronchi A. ASO Author Reflections: Evolving Concepts for Radiation Therapy in Extremity and Trunk Soft Tissue Sarcoma. Annals of Surgical Oncology 2018 Nov 12 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Løhre ET, Hjermstad MJ, Brunelli C, et al. Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study. Pain and Therapy 2018 Nov 10 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Sgrò A, Simioni A, Farina V, et al. Increasing the participation of medical students in surgical research: The Italian case and the role of research collaboratives. International Journal of Surgery 2018; 60: 111-112.
  Vai alla pagina della rivista
   

• Lanzi C, Cassinelli G. Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets forOptimal Activity. Molecules 2018; 23(11). pii: E2915.
  Vai alla pagina della rivista
   

• Gallo V, Vineis P, Cancellieri M, et al. Exploring causality of the association between smoking and Parkinson's disease. International Journal of Epidemiology 2018 Nov 20 [Epub ahead of print]
  Vai alla pagina della rivista
   

• D'Aguanno S, Valentini E, Tupone MG, et al. Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb. Journal of Experimental & Clinical Cancer Research 2018; 37(1): 278.
  Vai alla pagina della rivista
   

• D'Agostino M, De Paoli L, Conticello C, et al. Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. Critical reviews in oncology/hematology 2018; 132: 9-16.
  Vai alla pagina della rivista
   

• Gu F, Chen TH, Pfeiffer RM, et al. Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma. Human molecular genetics 2018; 27(23): 4145-4156.
  Vai alla pagina della rivista
   

Milano, 26 novembre 2018

• Mazzaferro V, El-Rayes BF, Droz Dit Busset M, et al. Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma. British Journal of Cancer 2018 Nov 13 [Epub ahead of print]
  Vai alla pagina della rivista
   

Per maggiori informazioni:

“Leggi l'abstract a cura dell’Istituto Nazionale dei Tumori (PDF)"

--------------------------------------------------------------------------------------------------------------------------------------------------------

Gli altri articoli apparsi nel corso della settimana sono i seguenti:

• Minicozzi P, Van Eycken L, Molinie F, et al. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer. International Journal of Cancer 2018 Nov 8 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Caleca L, Catucci I, Figlioli G, et al. Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction. Frontiers in Oncology 2018; 8:480
  Vai alla pagina della rivista
   

• Fortunato O, Borzi C, Milione M, et al. Circulating mir-320° promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk. International Journal Cancer 2018 Nov 13 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Orlandi E, Iacovelli NA, Rancati T, et al. Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients. Oral Oncology 2018; 86: 266-272.
  Vai alla pagina della rivista
   

• Zheng JS, Imamura F, Sharp SJ, et al. Association of plasma vitamin D metabolites with incident type 2 diabetes: EPIC-InterAct case-cohort study. Journal of Clinical Endocrinology and Metabolism 2018 Nov 9 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Bossi P. Prognostic Nutritional Index: an easy nutritional screening forpatients with head and neck cancer? ESMO Open 2018 Oct 24; 3(6): e000449.
  Vai alla pagina della rivista
   

• Dieci MV, Massari F, Giusti R, et al. Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM). ESMO Open. 2018 Oct 21; 3(6): e000389.
  Vai alla pagina della rivista
   

• Bracarda S, Porta C, Sabbatini R, et al. Angiogenic and immunological pathways in metastatic renal cell carcinoma: A counteracting paradigm or two faces of the same medal? The GIANUS Review.
  Critical Reviews in Oncology/Hematology 2018 Aug 1 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Oing C, Giannatempo P, Honecker F, et al. Palliative treatment of germ cell cancer. Cancer Treatment Reviews 2018; 71: 102-107.
  Vai alla pagina della rivista
   

• Fallon M, Ripamonti CI. Reply to the letter to the editor 'Small repeated boluses are unreliable to provide rapid analgesia with intravenous morphine titration and mislead conversion ratio to oral morphine' by Mercadante S.Annals of Oncology 2018; 29(10): 2148-2149.
  Vai alla pagina della rivista

Milano, 19 novembre 2018

• Raspagliesi F, Bogani G, Matteucci L, et al. Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC-IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional Study. International Journal of Gynecological Cancer 2018; 28(9): 1706-1713.
  Vai alla pagina della rivista
   

Per maggiori informazioni:

“Leggi l'abstract a cura dell’Istituto Nazionale dei Tumori (PDF)"

--------------------------------------------------------------------------------------------------------------------------------------------------------

Gli altri articoli apparsi nel corso della settimana sono i seguenti:

• Huber V, Vallacchi V, Fleming V, et al. Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma. Journal of Clinical Investigation 2018 Nov 5 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Secreto G, Girombelli A, Krogh V. Androgen excess in breast cancer development: implications for prevention and treatment. Endocrine-Related Cancer 2018 Nov 1 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Corti C, Manfredi V, Massimino M, et al. Cognitive functioning of pediatric patients with brain tumor: an investigation of the role of gender. Child’s Nervous System 2018; 34(12): 2415-2423.
  Vai alla pagina della rivista
   

• Barra F, Leone Roberti U, et al. New prophylactics human papilloma virus (HPV) vaccines against cervical cancer. Journal of Obstetrics and Gynaecology 2018 Oct 27  [Epub ahead of print]
  Vai alla pagina della rivista
   

• Giannini L, Incandela F, Fiore M, et al. Radiation-Induced Sarcoma of the Head and Neck: A Review of the Literature. Frontiers in Oncology 2018; 8:449.
  Vai alla pagina della rivista
   

• Piazza C, Peretti G, Vander Poorten V. Editorial: Advances in Transoral Approaches for Laryngeal Cancer. Frontiers in Oncology 2018; 8: 455.
  Vai alla pagina della rivista
   

• Bogani G, Ditto A, Martinelli F, Chiappa et al. Investigating the Role of Minimally Invasive Radical Hysterectomy in Cervical Cancer.  Journal of Investigative Surgery 2018 Nov 2  [Epub ahead of print]
  Vai alla pagina della rivista
   

• De Santis F, Del Vecchio M, Castagnoli L, et al. Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting. Cytokine Growth Factor Rev. 2018 Oct 30 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Incandela F, Paderno A, Missale F, et al. Glottic exposure for transoral laser microsurgery: Proposal of a mini-version of the laryngoscore. Laryngoscope 2018 Nov 8 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Imbimbo M, Ottaviano M, Vitali M, et al. Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). Cancer Treatment Reviews 2018; 71: 76-87
  Vai alla pagina della rivista
   

• Somigliana E, Terenziani M, Filippi F, et al. Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence. Journal of Assisted Reproduction and Genetics 2018 Oct 25 [Epub ahead of print]
  Vai alla pagina della rivista

Milano, 12 novembre 2018

Gli altri articoli apparsi nel corso della settimana sono i seguenti:
 

• Callegaro D, Miceli R, Bonvalot S, et al. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres. European Journal of Cancer 2018; 105:19-27.
  Vai alla pagina della rivista
   

• Cortinovis U, Sala L, Bonomi S, et al. Rectus Abdominis Myofascial Flap for Vaginal Reconstruction After Pelvic Exenteration. Annals of Plastic Surgery 2018; 81(5): 576-583.
  Vai alla pagina della rivista
   

• Muscatello LV, Di Oto E, Sarli G, et al. HER2 Amplification Status in Feline Mammary Carcinoma: A Tissue Microarray-Fluorescence In Situ Hydridization-Based Study. Veterinary Pathology 2018 Nov 1 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Amelio I, Mancini M, Petrova V, et al. p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression. PNAS 2018 Oct 31 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Canese R, Palombelli G, Chirico M, et al.  Integration of MRI and MRS approaches to monitor molecular imaging and metabolomic effects of trabectedin on a preclinical ovarian cancer model. NMR in Biomedicine 2018 Oct 30 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Tuccitto A, Shahaj E, Vergani E, et al. Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy. Virchows Archiv 2018 Oct 29 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Rossi G, Redaelli V, Perego P, et al. Tau Mutations as a Novel Risk Factor for Cancer-Response. Cancer Research 2018 Oct 29 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Bossi P, Miceli R, Granata R, et al. In Reply to Fakhry et al. International Journal of  Radiation Oncology Biology Physics 2018; 102(3): 670-671.
  Vai alla pagina della rivista
   

• Simon C, Caballero C, Gregoire V, et al. Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 'Best of' and 24954 'larynx preservation' study.European Journal of Cancer 2018; 103: 69-77.
  Vai alla pagina della rivista
   

• Maines F, De Giorgi U, Procopio G, et al. Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program. Future Oncology 2018; 14(26): 2691-2699.
  Vai alla pagina della rivista
   

• Pinna AD, Yang T, Mazzaferro V, et al. Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma. Annals of Surgery 2018; 268(5): 868-875.
  Vai alla pagina della rivista
   

Milano, 5 novembre 2018

• Zinzani PL, Santoro A, Chiti A, et al. Italian expert panel consensus statement on the optimal use of PD-1 blockade therapy in classical Hodgkin lymphoma. Leukemia & Lymphoma 2018 Oct 15: 1-10.
  Vai alla pagina della rivista
   

Per maggiori informazioni:

“Leggi l'abstract a cura dell’Istituto Nazionale dei Tumori (PDF)"

--------------------------------------------------------------------------------------------------------------------------------------------------------

Gli altri articoli apparsi nel corso della settimana sono i seguenti:

• Ciceri S, Gamba B, Corbetta P, et al. Genetic and epigenetic analyses guided by high resolution whole-genome SNP array reveals a possible role of CHEK2 in Wilms tumour susceptibility.
  Oncotarget 2018; 9(75): 34079-34089.
  Vai alla pagina della rivista
   

• Necchi A, Anichini A, Raggi D, et al. Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study. Journal of Clinical Oncology 2018 Oct 20  [Epub ahead of print]
  Vai alla pagina della rivista
   

• Corti C, Poggi G, Massimino M, et al. Visual perception and spatial transformation of the body in children and adolescents with brain tumor. Neuropsychologia. 2018 Oct 22 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Dragani TA, Colombo F, Pavlisko EN, et al. Authors' Reply. Carcinogenesis 2018 Oct 23 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Moriggi M, Giussani M, Torretta E, et al. ECM Remodelling in Breast Cancer with Different Grade: Contribution of 2D-DIGE Proteomics. Proteomics 2018 Oct 24 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Veneroni L, Gaggiotti P, Ciceri D, et al. From the seventh floor to seventh heaven. Tumori. 2018 Oct 24  [Epub ahead of print]
  Vai alla pagina della rivista
   

• Walterhouse DO, Barkauskas DA, Hall D, et al. Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative Groups. Journal of Clinical Oncology 2018 Oct 23 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Savina M, Litière S, Italiano A, et al. Surrogate endpoints in advanced sarcoma trials: a meta-analysis. Oncotarget 2018 Oct 2; 9(77): 34617-34627.
  Vai alla pagina della rivista
   

• Sarink D, Schock H, Johnson T, et al. Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort. BMC Cancer 2018 Oct 22; 18(1): 1010.
  Vai alla pagina della rivista
   

• Hauschild A, Dummer R, Schadendorf D, et al. Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma. Journal of Clinical Oncology 2018 Oct 22: JCO1801219.
  Vai alla pagina della rivista
   

• Rodríguez-Barranco M, Salamanca-Fernández E, Fajardo ML, et al. Patient, tumor, and healthcare factors associated with regional variability in lung cancer survival: a Spanish high-resolution population-based study. Clin Transl Oncol. 2018 Oct 19 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Lambertini M, Martel S, Campbell C, et al. Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials. Cancer 2018 Oct 18 [Epub ahead of print]
  Vai alla pagina della rivista
   

Milano, 29 ottobre 2018

• Kaasa S, Loge JH, Aapro M, et al. Integration of oncology and palliative care: a Lancet Oncology Commission. Lancet Oncology  2018 Oct 17
  Vai alla pagina della rivista
   

Per maggiori informazioni:

“Leggi l'abstract a cura dell’Istituto Nazionale dei Tumori (PDF)"

--------------------------------------------------------------------------------------------------------------------------------------------------------

Gli altri articoli apparsi nel corso della settimana sono i seguenti:

• Camisaschi C, Renne SL, Beretta V, et al. Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients. BMC Cancer 2018; 18(1): 983.
  Vai alla pagina della rivista
   

• Johnstone PAS, Boulware D, Djajadiningrat R, et al. Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes. European Urology Focus 2018 Oct 13 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Huseinovic E, Winkvist A, Freisling H, et al. Timing of eating across ten European countries - results from the European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study. Public Health Nutrition 2018 Oct 17  [Epub ahead of print]
  Vai alla pagina della rivista
   

• Bersanelli M, Giannarelli D, Castrignanò P, et al. INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. Immunotherapy 2018; 10(14): 1229-1239.
  Vai alla pagina della rivista
   

• Baratti D.  ASO Author Reflections: Pathologic Classification of Pseudomyxoma Peritonei.  Annals of Surgical Oncology 2018 Oct 15 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Garassino MC, Torri V, Colombo MP, et al. Choosing the Best Chemotherapy Agent to Boost Immune Checkpoint Inhibition Activity. Cancer Research 2018; 78(20): 5729-5730.
  Vai alla pagina della rivista
   

• Garofalo M, Villa A, Rizzi N, et al. Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies. Viruses 2018; 10(10): 558.
  Vai alla pagina della rivista
   

• Carbone A, Gloghini A. Checkpoint blockade therapy resistance in Hodgkin's lymphoma. Lancet 2018; 392(10154): 1194-1196.
  Vai alla pagina della rivista
   

• Necchi A, Messina A, Briganti A.  Re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 2018;74:294-306: Validating VI-RADS Criteria Within Immune-oncology Strategies (VI-RADS-IO). European Urology 2018; 74(5): e107-e108.
  Vai alla pagina della rivista
   

Milano, 22 ottobre 2018

 

Gli altri articoli apparsi nel corso della settimana sono i seguenti:
 

• Vujanic GM, Gessler M, Ooms AHAG, et al. The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol. Nature Reviews. Urology 2018 Oct 11 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Necchi A, Pond GR, Moschini M, et al. Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy inPatients With Muscle-Invasive Bladder Cancer. Clinical Genitourinary Cancer 2018 Sep 13 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Fucà G, Galli G, Poggi M, et al. Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy. Targeted Oncology 2018 Oct 10 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Schmitz S, Caballero C, Locati LD. Perspectives on window of opportunity trials in head and neck cancer: lessons from the EORTC 90111-24111-NOCI-HNCG study. European Journal of Cancer 2018 Oct 6 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Galot R, Le Tourneau C, Guigay J, et al. "Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach."
  Annals of Oncology 2018 Oct 11 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Brok J, Pritchard-Jones K, Spreafico F. Follow-up surveillance of Wilm's tumour - Authors' reply. Lancet Oncology 2018;19(10): e503
  Vai alla pagina della rivista
   

• Morano F, Sclafani F. Duration of first-line treatment for metastatic colorectal cancer: Translating the available evidence into general recommendations for routine practice. Critical Reviews in Oncology/Hematology 2018; 131:53-65.
  Vai alla pagina della rivista
   

• Loglio A, Viganò M, Grossi G, et al. Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma. Digestive and Liver Disease 2018 Sep 7  [Epub ahead of print]
  Vai alla pagina della rivista
   

• Ready N, Farago AF, de Braud F, et al. Third-Line Nivolumab Monotherapy in Recurrent Small Cell Lung Cancer: CheckMate 032. Journal of Thoracic Oncology 2018 Oct 10  [Epub ahead of print]
  Vai alla pagina della rivista
   

• Qian F, Wang S, Mitchell J, et al. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. Journal of the National Cancer Institute 2018 Oct 12 [Epub ahead of print]
  Vai alla pagina della rivista
   

Milano, 15 ottobre 2018

 

Gli altri articoli apparsi nel corso della settimana sono i seguenti:
 

• Casali PG, Bielack S, Abecassis N, et al. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2018;29 (Supplement  4)
  Vai alla pagina della rivista
   

• De Cesare M. High Efficacy of Intravenous Gimatecan on Human Tumor Xenografts. Anticancer Research 2018; 38(10): 5783-5790.
  Vai alla pagina della rivista
   

• Ferrari A, Orbach D, Affinita MC, et al. Evidence of hydroxyurea activity in children withpretreated desmoid-type fibromatosis: A new option in the armamentarium of systemic therapies. Pediatric Blood & Cancer 2018: e27472.
  Vai alla pagina della rivista
   

• Fallon M, Giusti R, Aielli F, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Annals of Oncology 2018; 29(Supplement 4): iv166-iv191.
  Vai alla pagina della rivista
   

• Nizri E, Kusamura S, Fallabrino G, et al. Dose-Dependent Effect of Red Blood Cells Transfusion on Perioperative and Long-Term Outcomes in Peritoneal Surface Malignancies Treated with Cytoreduction and HIPEC. Annals of Surgical Oncology 2018; 25(11): 3264-3270.
  Vai alla pagina della rivista
   

• Corti C, Manfredi V, Massimino M, et al. Cognitive functioning of pediatric patients with brain tumor: an investigation of the role of gender. Child's Nervous System 2018 Oct 1 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Nizri E, Kusamura S, Deraco M. Blood Transfusion in Cytoreductive Surgery:Better Not at All. Annals of Surgical Oncology 2018 Oct 1 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Moskowitz CH, Walewski J, Nademanee A, et al. Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse. Blood 2018 Sep 28 [Epub ahead
  of print]
  Vai alla pagina della rivista
   

• Habberstad R, Frøseth TCS, Aass N, et al. The Palliative Radiotherapy and Inflammation Study (PRAIS) - protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain.
  BMC Palliative Care 2018; 17(1): 110.
  Vai alla pagina della rivista
   

• Cascella M, Bimonte S, Saettini F, et al. The challenge of pain assessment in children with cognitive disabilities: Features and clinical applicability of different observational tools. Journal of Paediatrics and Child Health 2018 Sep 27 [Epub ahead of print]
  Vai alla pagina della rivista
   

• Bossi P, Miceli R, Granata R, et al. In Reply to Fakhry et al.  International Journal of Radiation Oncology, Biology, Physics 2018; 102(3): 670-671.
  Vai alla pagina della rivista
   

• Janjigian YY, Bendell J, Calvo E, et al. CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer. Journal of Clinical Oncology 2018; 36(28): 2836-2844.
  Vai alla pagina della rivista
   

Milano, 8 ottobre 2018